IGF1R and neoplasm: A critical finding is that miR-9, as a tumor-suppressive microRNA, operated through the IGF1R pathway to regulate the targeting of cyclin B1 and N-cadherin and the upregulation of E-cadherin in CRC cells in the HG-concentration medium (Figure 4C–E).